drugset / Trial / NCT00196352

A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.

NCT00196352

Phase 3 Completed 320 enrolled Duramed Research
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This study is being conducted to evaluate the safety of ethinyl an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three consecutive years.

Timeline

Start
2003-05
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 0.15 mg Oral
Subject ethinyl estradiol Small molecule 0.01 mg Oral
Subject ethinyl estradiol Small molecule 0.03 mg Oral

Indications

No indication recorded.